Henan Lingrui Pharmaceutical Co (SHSE:600285) Total Current Assets : ¥2,949 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Henan Lingrui Pharmaceutical Co's total current assets for the quarter that ended in Mar. 2024 was ¥2,949 Mil.

Henan Lingrui Pharmaceutical Co Total Current Assets Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co Total Current Assets Chart

Henan Lingrui Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

1,754.36

1,916.54

2,131.24

2,508.39

2,598.93

Henan Lingrui Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Current Assets	Get a 7-Day Free Trial															2,594.58	2,390.81	2,446.36	2,598.93	2,949.50

Henan Lingrui Pharmaceutical Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Henan Lingrui Pharmaceutical Co's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1499.101	+	510.865	+	467.353	+	121.614
	=	2,599

Henan Lingrui Pharmaceutical Co's Total Current Assets for the quarter that ended in Mar. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1526.721	+	720.719	+	459.383	+	242.676
	=	2,949

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Henan Lingrui Pharmaceutical Co's Liquidation Value for the quarter that ended in Mar. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1526.721	-	2039.865	+	0.75 * 284.099	+	0.5 * 459.383
=	-70

Henan Lingrui Pharmaceutical Co Total Current Assets Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Henan Lingrui Pharmaceutical Co (SHSE:600285) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » Total Current Assets

Traded in Other Exchanges

N/A

Address

No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550

Website

http://www.lingrui.com

Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.

Executives

Wu Xi Zhen	Director
Li Jin	Supervisors
Ye Qiang	senior management
Chen Yan	Directors, senior managers
Wu Hui Bin	senior management
Yu Peng	Director
Zhao Zhi Jun	Director
Li Lei	senior management
Feng Guo Xin	Directors, senior managers
Pan Zi Run	Director
Xiong Wei Zheng	Director
Tang Wei	Supervisors
Cheng Jian Jun	Director
Zhang Jun Bing	Director
Xia Hui	senior management

Henan Lingrui Pharmaceutical Co (SHSE:600285) Headlines

No Headlines